Skip to main content
Erschienen in: Supportive Care in Cancer 1/2023

01.01.2023 | Correspondence

A systematic review of m-health apps on managing side effects of breast cancer treatment

verfasst von: Ausanee Wanchai, Elizabeth A. Anderson, Jane M. Armer

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

After breast cancer treatment, women with breast cancer may experience distress caused by treatment side effects, both in physical and psychological aspects. Technology use is increasing in favor among women. Therefore, it is essential to update the scientific evidence regarding mobile and web apps’ effectiveness in managing the side effects of breast cancer treatments for breast cancer survivors. The purpose of this systematic review was to investigate the scientific evidence on the effectiveness of mobile and web apps in managing the side effects of breast cancer treatments among this group.

Methods

A literature search was conducted using ScienceDirect, Scopus, PubMed, CINAHL, and Cochrane. Published papers in English focused on mobile and web apps and the side effects of breast cancer treatment in breast cancer survivors were selected. The search reviewed studies from January 2011 to December 2021. From a total of 925 retrieved manuscripts, 11 studies were included for analysis.

Results

The findings showed that mobile apps were more frequently used and more likely to be an effective method for managing the side effects of breast cancer treatment among breast cancer survivors. The content in web or mobile apps for breast cancer survivors should include five categories: (1) information about cancer, (2) overview of cancer care, (3) opportunities for interaction with other people, (4) symptom management strategies, and (5) feedback about cancer treatment side effect management. However, a few studies examined the effects of a combination of mobile and web apps in managing breast cancer treatment side effects. Therefore, future research is needed to examine solo and combination use. In addition, more rigorous studies are warranted to examine these interventions.

Conclusions

Nurses may refer survivors to these resources to obtain more information and effectively manage the signs and symptoms of breast cancer and its treatment side effects.
Literatur
15.
19.
Zurück zum Zitat Rincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E (2017) Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: systematic review. JMIR Mhealth Uhealth 5(12):e187. https://doi.org/10.2196/mhealth.8741CrossRef Rincon E, Monteiro-Guerra F, Rivera-Romero O, Dorronzoro-Zubiete E, Sanchez-Bocanegra CL, Gabarron E (2017) Mobile phone apps for quality of life and well-being assessment in breast and prostate cancer patients: systematic review. JMIR Mhealth Uhealth 5(12):e187. https://​doi.​org/​10.​2196/​mhealth.​8741CrossRef
21.
Zurück zum Zitat Benjumea J, Ropero J, Rivera-Romero O, Dorronzoro-Zubiete E, Carrasco A (2020) Assessment of the fairness of privacy policies of mobile health apps: Scale development and evaluation in cancer apps. JMIR MHealth UHealth 8(7):e17134–e17134. https://doi.org/10.2196/17134CrossRef Benjumea J, Ropero J, Rivera-Romero O, Dorronzoro-Zubiete E, Carrasco A (2020) Assessment of the fairness of privacy policies of mobile health apps: Scale development and evaluation in cancer apps. JMIR MHealth UHealth 8(7):e17134–e17134. https://​doi.​org/​10.​2196/​17134CrossRef
22.
Zurück zum Zitat Hutton L et al (2018) Assessing the privacy of mhealth apps for self-tracking: heuristic evaluation approach. JMIR MHealth UHealth 6(10):e9217CrossRef Hutton L et al (2018) Assessing the privacy of mhealth apps for self-tracking: heuristic evaluation approach. JMIR MHealth UHealth 6(10):e9217CrossRef
23.
Zurück zum Zitat Flors-Sidro JJ, Househ M, Abd-Alrazaq A, Vidal-Alaball J, Fernandez-Luque L, Sanchez-Bocanegra CL (2021) Analysis of diabetes apps to assess privacy-related permissions: systematic search of apps. JMIR Diabetes 6(1):e16146. https://doi.org/10.2196/16146CrossRef Flors-Sidro JJ, Househ M, Abd-Alrazaq A, Vidal-Alaball J, Fernandez-Luque L, Sanchez-Bocanegra CL (2021) Analysis of diabetes apps to assess privacy-related permissions: systematic search of apps. JMIR Diabetes 6(1):e16146. https://​doi.​org/​10.​2196/​16146CrossRef
26.
27.
28.
Zurück zum Zitat GrašičKuhar C, GortnarCepeda T, Kovač T, Kukar M, RužićGorenjec N (2020) Mobile app for symptom management and associated quality of life during systemic treatment in early-stage breast cancer: nonrandomized controlled prospective cohort study. JMIR MHealth UHealth 8(8):e17408–e17408. https://doi.org/10.2196/17408CrossRef GrašičKuhar C, GortnarCepeda T, Kovač T, Kukar M, RužićGorenjec N (2020) Mobile app for symptom management and associated quality of life during systemic treatment in early-stage breast cancer: nonrandomized controlled prospective cohort study. JMIR MHealth UHealth 8(8):e17408–e17408. https://​doi.​org/​10.​2196/​17408CrossRef
32.
Zurück zum Zitat Ghanbari E, Yektatalab S, Mehrabi M (2021) Effects of psychoeducational interventions using mobile apps and mobile-based online group discussions on anxiety and self-esteem in women with breast cancer: randomized controlled trial. JMIR MHealth UHealth 9(5):e19262–e19262. https://doi.org/10.2196/19262CrossRef Ghanbari E, Yektatalab S, Mehrabi M (2021) Effects of psychoeducational interventions using mobile apps and mobile-based online group discussions on anxiety and self-esteem in women with breast cancer: randomized controlled trial. JMIR MHealth UHealth 9(5):e19262–e19262. https://​doi.​org/​10.​2196/​19262CrossRef
33.
34.
Zurück zum Zitat Graetz I, McKillop CN, Stepanski E, Vidal GA, Anderson JN, Schwartzberg LS (2018) Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. J Cancer Surviv Res Pract 12(4):431–440. https://doi.org/10.1007/s11764-018-0682-zCrossRef Graetz I, McKillop CN, Stepanski E, Vidal GA, Anderson JN, Schwartzberg LS (2018) Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial. J Cancer Surviv Res Pract 12(4):431–440. https://​doi.​org/​10.​1007/​s11764-018-0682-zCrossRef
36.
Zurück zum Zitat Fu MR et al (2022) A Web- and mobile-based intervention for women treated for breast cancer to manage chronic pain and symptoms related to lymphedema: results of a randomized clinical trial. JMIR Cancer 8(1):e29485. https://doi.org/10.2196/29485CrossRef Fu MR et al (2022) A Web- and mobile-based intervention for women treated for breast cancer to manage chronic pain and symptoms related to lymphedema: results of a randomized clinical trial. JMIR Cancer 8(1):e29485. https://​doi.​org/​10.​2196/​29485CrossRef
37.
Zurück zum Zitat Higgins J, Savović J, Page M, Elbers R, Sterne J (2022) Assessing risk of bias in a randomized trial,” in Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022), J. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. Page, and V. Welch, Eds. Cochrane. www.training.cochrane.org/handbook. Higgins J, Savović J, Page M, Elbers R, Sterne J (2022) Assessing risk of bias in a randomized trial,” in Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022), J. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. Page, and V. Welch, Eds. Cochrane. www.​training.​cochrane.​org/​handbook.
38.
44.
Zurück zum Zitat Richards R, Kinnersley P, Brain K, Staffurth J, Wood F (2019) The preferences of patients with cancer regarding apps to help meet their illness-related information needs: Qualitative interview study. JMIR MHealth UHealth 7(7):e14187–e14187. https://doi.org/10.2196/14187CrossRef Richards R, Kinnersley P, Brain K, Staffurth J, Wood F (2019) The preferences of patients with cancer regarding apps to help meet their illness-related information needs: Qualitative interview study. JMIR MHealth UHealth 7(7):e14187–e14187. https://​doi.​org/​10.​2196/​14187CrossRef
Metadaten
Titel
A systematic review of m-health apps on managing side effects of breast cancer treatment
verfasst von
Ausanee Wanchai
Elizabeth A. Anderson
Jane M. Armer
Publikationsdatum
01.01.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2023
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-022-07464-x

Weitere Artikel der Ausgabe 1/2023

Supportive Care in Cancer 1/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.